On the other hand, sleep problems like insomnia and sleep apnea can lead to serious health issues and even increase the risk ...

Natural treatment options for hypothyroidism may help manage symptoms but cannot replace treatments prescribed by your healthcare provider. Natural options include incorporating iodine, selenium, zinc ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Israel Prize winner Prof. Michal Schwartz says her team's work fighting Alzheimer's can lead to treatments that boost immune ...

Overall, DMTs are expected to dominate the global Alzheimer’s market, contributing 73.5% of the market by 2033, with drugs targeting Aβ making up the majority of this. Although the approval of the ...

People in the United States are living longer and with that comes increased rates of dementia. Dr. Josef Coresh, with NYU ...

Last month, the FDA granted approval to Eli Lilly’s donanemab - or Kisunla - for the treatment of Alzheimer’s disease. Its approval was based on the treatment demonstrating what the FDA ...

As the need for new Alzheimer's treatments grows, the market will become more crowded for pharma companies and segmentation will become an ever more useful tool in market research, drug ...

Alzheimer’s treatments are a potential $13 billion market by 2030, with major pharma cos investing heavily. Biogen and Eli Lilly have drugs like Leqembi and Kisunla available, but challenges remain.